BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11122746)

  • 1. Pleiotropic effects of statins.
    Farmer JA
    Curr Atheroscler Rep; 2000 May; 2(3):208-17. PubMed ID: 11122746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pleiotropic effects of statins].
    Mori S; Saito Y
    Nihon Rinsho; 2002 May; 60(5):875-81. PubMed ID: 12029988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.
    Egom EE; Rose RA; Neyses L; Soran H; Cleland JG; Mamas MA
    Crit Rev Clin Lab Sci; 2013; 50(3):79-89. PubMed ID: 23885725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications for statin pleiotropy.
    Liao JK
    Curr Opin Lipidol; 2005 Dec; 16(6):624-9. PubMed ID: 16276239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-lipid effects of statins: emerging new indications.
    Yildirir A; Müderrisoglu H
    Curr Vasc Pharmacol; 2004 Oct; 2(4):309-18. PubMed ID: 15320810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of statins: do they matter?
    Gotto AM; Farmer JA
    Curr Opin Lipidol; 2001 Aug; 12(4):391-4. PubMed ID: 11507323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
    de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
    Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and biomarkers of inflammation.
    Devaraj S; Rogers J; Jialal I
    Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A; Fisman EZ; Motro M; Adler Y
    Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pleiotropic effects of statins].
    Wolfovitz E
    Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.